ArticleMolecular medicine (Cambridge, Mass.)2025
Loss of Parkinson Disease Protein 7 (PARK7) upregulates ROS and cell migration and is associated with recurrent pregnancy loss.
Article in Molecular medicine (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSuccessful implantation is dependent on a synchronous dialogue between several proteins that act to control cellular dynamics including actin and microtubule reorganisation and cell motility. An impaired crosstalk can lead to complications including recurrent pregnancy loss (RPL) though the precise mechanisms remain unclear. Parkinson disease protein 7 (PARK7; encoding DJ-1), characterised for its participation in neurodegeneration, has emerged as a novel cytoskeletal and antioxidant regulator however, the role of DJ-1 in early pregnancy is unknown.
methodsWe employed systems biology approaches and functional studies in both human and murine models to examine the expression and role of DJ-1 during the window of implantation. LC–MS/MS proteomics analysis was conducted to identify proteins with differential expression between decidualized endometrial stromal cells (EnSC) with and without DJ-1 knockdown. Further, DJ-1 expression was manipulated using loss and gain of function strategies to investigate its impact on reactive oxygen species (ROS), the actin cytoskeleton and cellular motility. Lastly, knockdown of Palladin (a key actin regulator) and overexpression of Glutathione peroxidase 3 (GPX3) were used to investigate the downstream effects.
resultsEndometrial DJ-1 had the highest expression during the implantation window and loss of DJ-1 was associated with pregnancy loss in both humans and mice. The proteomics data revealed dysregulation of cytoskeletal protein, Palladin and antioxidant enzymes. Knockdown of DJ-1 using siRNA led to elevated ROS levels, increased actin polymerisation and resulted in increased cell motility towards aneuploidic signals. Conversely, DJ-1 overexpression led to the reversal of these effects. Moreover, knockdown of downstream target Palladin restored abnormal actin polymerization and prevented cell motility towards aneuploidic chemotactic signals. Further, overexpression of GPX3 mitigated ROS production and restored cell migration.
conclusionsTaken together, our findings identified an unexpected function of the DJ-1-Palladin axis in the endometrium and its function as a redox-sensitive chaperone and in cytoskeleton remodelling and migration. Thus, uncoupling of this axis may result in adverse pregnancy complications including recurrent pregnancy loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.